| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.1 |